These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14489378)

  • 21. [Endocrine-gynecologic observations during treatment with 4-hydroxy-17alpha-methyltestosterone].
    MARINACCIO L
    Minerva Ginecol; 1961 Feb; 13():197-201. PubMed ID: 13766780
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
    ZARA M; LUMBROSO A
    Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of combined corticoid and anabolic steroid on rabbit granulation tissue].
    MAURIZIO A; LAMI V; STRADA R
    Boll Soc Ital Biol Sper; 1963 Jan; 39():72-5. PubMed ID: 13934018
    [No Abstract]   [Full Text] [Related]  

  • 24. USE OF METHANDROSTENOLONE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    HECKEL RV; CLARK DT; BERMAN M; HALL RC
    Dis Nerv Syst; 1964 Mar; 25():171-2. PubMed ID: 14127899
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of urinary metabolites of 17alpha-methyltestosterone.
    RONGONE EL; SEGALOFF A
    J Biol Chem; 1962 Apr; 237():1066-7. PubMed ID: 14493684
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of protein metabolism and electrolyte balance in man during treatment with 1-dehydro-17alpha-methyltestosterone].
    MARTINA G; MORRA C; RASETTI L
    Minerva Med; 1960 Mar; 51():971-7. PubMed ID: 14421757
    [No Abstract]   [Full Text] [Related]  

  • 27. [Exploration of the turnover of erythrocytic P during treatment with 1-dehydro-17alpha-methyltestosterone].
    JACONO G; DE LUCA R; BRANCACCIO A; D'ALESSANDRO B; GALDIERO F
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():39-41. PubMed ID: 14450797
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effectes of ethinyl estradiol, 17alpha-ethyl-19-nortestosterone and methyltestosterone on the plasma clearance on infused cortisol.
    MARKS LJ; BENJAMIN G; DUNCAN FJ; O'SULLIVAN VI
    J Clin Endocrinol Metab; 1961 Jul; 21():826-32. PubMed ID: 13766952
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the anabolic activity of methandrostenolone (1-dehydro-17 alpha-methyltestosterone)].
    RAYMONDI G; CLAUSI-SCHETTINI G
    Minerva Med; 1960 Mar; 51():977-80. PubMed ID: 14436643
    [No Abstract]   [Full Text] [Related]  

  • 30. EFFECT OF ANABOLIC STEROIDS ON LIVER FUNCTION TESTS IN RABBITS.
    CARMICHAEL RH; WILSON C; MARTZ BL
    Proc Soc Exp Biol Med; 1963; 113():1006-8. PubMed ID: 14073093
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of anabolic hormones and ferric dextran upon the progeria-like syndrome produced by dihydrotachysterol.
    SELYE H; GOLDIE I; STREBEL R
    Gerontologia; 1963; 7():94-104. PubMed ID: 13987849
    [No Abstract]   [Full Text] [Related]  

  • 32. [4-Chlorotestosterone acetate and 4-hydroxy-17a-methyltestosterone in the treatment of so-called "tropical asthenia"].
    BARUFFA G
    Acta Med Ital Med Trop Subtrop Gastroenterol; 1961 Mar; 16():65-7. PubMed ID: 13865539
    [No Abstract]   [Full Text] [Related]  

  • 33. [THE ACTION OF ANABOLIC STEROIDS IN CHRONIC RENAL INSUFFICIENCY].
    COMAR OB; REDA T
    Minerva Urol; 1963; 15():109-14. PubMed ID: 14050349
    [No Abstract]   [Full Text] [Related]  

  • 34. Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
    Parr MK; Blatt C; Zierau O; Hess C; Gütschow M; Fusshöller G; Opfermann G; Schänzer W; Diel P
    Endocrinology; 2011 Dec; 152(12):4718-28. PubMed ID: 21990312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DIETETICS AND THE TREATMENT OF HEPATIC GLYCOGENOSIS].
    FRANCOIS R; JARLOT B; RUITON-UGLIENGO H; RUITON-UGLIENGO A
    Sem Hop; 1964 Apr; 40():1049-53. PubMed ID: 14147542
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and experimental notes on the androgenic activity of 9 alpha-fluoro-11 beta-hydroxy-17-methyltestosterone].
    DE LUCA R; BRANCACCIO A; D'ALESSANDRO B; JACONO G
    Gazz Med Ital; 1960 Jan; 119():1-3. PubMed ID: 13814875
    [No Abstract]   [Full Text] [Related]  

  • 37. [The action of 4-hydroxy-17 alpha-methyltestosterone on hepatic function in the elderly].
    KAUCHTSCHISCHWILI GM
    G Gerontol; 1960 Aug; 8():789-94. PubMed ID: 13751848
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of the protein-anabolizing property of 4-hydroxy-17 alpha-methyl-testosterone].
    SALA G; CESANA A; FEDRIGA G
    Minerva Med; 1960 Apr; 51():1295-300. PubMed ID: 14440891
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of severe bone pain in generalized neoplastic disease with combined anabolic steroids (deladumone).
    SEAMAN AJ
    Curr Ther Res Clin Exp; 1959 Oct; 1():64-8. PubMed ID: 14444340
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of localized osseous atrophy treated with estrogens].
    VICARI F
    Rass Medica; 1953 May; 30(5):81-3. PubMed ID: 13100714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.